The Nigerian Institute of Medical Research (NIMR) on Sunday announced a milestone in its Safety and Antimicrobial Resistance of Mass Administration of Azithromycin (SARMAAN) project, saying about 1.4 million children under the age of five have been administered with Azithromycin. Azithromycin is a safe and effective medication recommended by the World Health Organisation (WHO) to combat high childhood mortality rates. The programme targets areas with under-five mortality exceeding 80 per 1,000 births and infant mortality surpassing 60 per 1,000 births. Speaking during an engagement meeting with the Minister of Health and Social Welfare, Dr Tunji Alausa, the Director-General of NIMR,
The post NIMR reaches over 1.4m under 5 children with Azithromycin treatment appeared first on Guardian Nigeria News.